Fagron NV (OTCMKTS:ARSUF – Get Free Report) was the recipient of a large drop in short interest in the month of January. As of January 15th, there was short interest totaling 248 shares, a drop of 91.9% from the December 31st total of 3,076 shares. Based on an average daily volume of 1,000 shares, the short-interest ratio is currently 0.2 days. Based on an average daily volume of 1,000 shares, the short-interest ratio is currently 0.2 days.
Fagron Price Performance
OTCMKTS ARSUF remained flat at $26.81 on Tuesday. The company’s stock had a trading volume of 8,000 shares, compared to its average volume of 633. The company’s 50-day moving average price is $24.03 and its two-hundred day moving average price is $24.25. Fagron has a 52 week low of $23.50 and a 52 week high of $26.81.
About Fagron
Fagron (OTCMKTS:ARSUF) is a global pharmaceutical compounding company that supplies raw materials, equipment and services to compounding pharmacies, hospitals and healthcare practitioners. Its portfolio encompasses a range of pharmaceutical ingredients, dosage forms and specialized compounding solutions designed to meet patient-specific needs. The company supports the preparation of customized medications in areas such as dermatology, pain management, hormone replacement therapy and veterinary medicine, providing both sterile and non-sterile compounding products.
Headquartered in Rotterdam, the Netherlands, Fagron operates in more than 55 countries across Europe, the Americas, Asia-Pacific and the Middle East & Africa.
Read More
- Five stocks we like better than Fagron
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Fagron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fagron and related companies with MarketBeat.com's FREE daily email newsletter.
